Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc
Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc
Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
tinguished from Sertoli cell nodules, and<br />
Leydig cell tumours, and rete adenomas.<br />
Sertoli cell nodules, however, are small,<br />
incidentally discovered, non neoplastic<br />
lesions composed of aggregates of small<br />
tubules lined by immature Sertoli cells<br />
and contain prominent basement membrane<br />
deposits. The rete adenomas<br />
occur within the dilated lumens of the<br />
rete testis.<br />
Prognosis<br />
Most Sertoli cell tumours are benign.<br />
Malignant Sertoli cell tumour<br />
ICD-O code 8640/3<br />
Epidemiology<br />
Malignant Sertoli cell tumour not otherwise<br />
specified is rare {1194}. Less than 50<br />
cases have been reported. Age distribution<br />
does not differ from that of the benign<br />
form, occurring from childhood to old age.<br />
Clinical features<br />
Some patients present with metastases;<br />
most commonly to inguinal, retroperitoneal<br />
and/or supraclavicular lymph<br />
nodes. Approximately one third has<br />
gynecomastia at presentation, but apart<br />
from that no specific lesions or syndrome<br />
are known to be associated with malignant<br />
Sertoli cell tumour.<br />
Macroscopy<br />
They tend to be larger than the benign<br />
counterparts {2894}, usually more than 5<br />
cm but range 2 to 18 cm. The macroscopic<br />
appearance may differ from that<br />
of the benign tumour by necrosis and<br />
haemorrhage.<br />
Histopathology<br />
Microscopically, the cellular features and<br />
Fig. 4.75 Sclerosing type of Sertoli cell tumour.<br />
growth patterns are similar to those of the<br />
benign counterpart but tend to be more<br />
variable within the same tumour and<br />
between tumours. The solid, sheet-like<br />
growth pattern is often prominent. The<br />
nuclei may be pleomorphic with one or<br />
more nucleoli, which are usually not very<br />
prominent. Mitotic figures may be numerous,<br />
and necrosis may occur. A fibrous,<br />
hyalinized or myxoid stroma occurs in<br />
varying amounts, but is usually sparse.<br />
Lymphovascular invasion may be seen.<br />
Lymphoplasmacytic infiltration is reported<br />
in some cases varying from sparse to<br />
pronounced and even with secondary<br />
germinal centres.<br />
The most important differential diagnoses<br />
are classical and spermatocytic seminoma<br />
and variants of yolk sac tumour, however<br />
granulomatous reactions and<br />
intratubular germ cell neoplasia are not<br />
present in the surrounding testicular<br />
parenchyma. Endometrioid adenocarcinoma<br />
and metastases, and among the<br />
latter especially adenocarcinomas with<br />
pale or clear cytoplasm, as well as<br />
melanoma should also be considered.<br />
Immunohistochemical staining is helpful<br />
in defining the Sertoli cell nature of the<br />
tumour but not its malignant potential<br />
{1074,1194}. The tumour cells are<br />
cytokeratin and vimentin positive and<br />
they may also be positive for epithelial<br />
membrane antigen. They stain for inhibin<br />
A, but usually not very intensely, and they<br />
may be S100 positive. They are PLAP<br />
and CEA negative.<br />
Granulosa cell tumour group<br />
Definition<br />
Granulosa cell tumours of the testis are<br />
morphologically similar to their ovarian<br />
counterparts. Two variants are distinguished:<br />
adult and juvenile types.<br />
Fig. 4.76 Malignant Sertoli cell tumour.<br />
A<br />
Fig. 4.77 Malignant Sertoli cell tumour. A Solid and tubular components. B Vimentin staining in the tubular<br />
component.<br />
B<br />
Sex cord / gonadal stromal tumours 255